Financials
- Market Capitalization 20.15 B
- Employee 30 K
- Founded 2020
- CEO Scott A. Smith
- Website www.viatris.com
- Headquarter Delaware, United States
- FIGI BBG00Y4RQNH4
- Industry Fabricantes de medicamentos — especializados y genéricos
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-4.15
Relación precio/flujo de caja
—
Dividendos por acción
0.48
Rendimiento por dividendo, %
3.86
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 433 | ZTS Zoetis Inc. Class A Common Stock | 75.64 USD | +1.16% | +5.29% | +1.87% | -48.31% | 31.26 B USD | ||
| 450 | TAK Takeda Pharmaceutical Company Limited American Depositary Share | 18.69 USD | -0.21% | +3.78% | +0.70% | +31.76% | 29.11 B USD | ||
| 698 | NBIX Neurocrine Biosciences, Inc. - Common Stock | 141.37 USD | -0.75% | -2.29% | -10.69% | -2.50% | 14.37 B USD | ||
| 826 | ELAN Elanco Animal Health Incorporated Common Stock | 22.58 USD | -1.48% | -1.10% | -3.50% | +0.83% | 11.28 B USD |